Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Auxilium Pharmaceuticals, Inc.    AUXL   US05334D1072

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

Auxilium Pharmaceuticals, Inc. : quaterly earnings release

02/21/2013 | 09:15am US/Eastern

The company will report its earnings for Q4 2012 on 02/26/2013. Generally, the company reports earnings worse than estimates. In recent months, the 9 analysts from Thomson Reuters consensus have revised their EPS estimates upward. Below, a summary of publications and estimates for Auxilium Pharmaceuticals, Inc..

Quarterly resultsQ1
2012
Q2
2012
Q3
2012
Q4
2012 (e)
Q1
2013 (e)
Sales
Million $
Released
Forecast
Spread
73,6
71,2
3,4%
78,2
74,0
5,7%
71,0
79,3
-10%

171

80,4
Operating income (EBITDA)
Million $
Released
Forecast
Spread

-4,09
9,71
-2,28
526%
-8,06
-3,00
-169%

90,4

2,13
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-1,90
-4,78
60%
7,60
-2,93
360%
-10,7
-2,58
-316%

87,8

2,10
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-1,70

7,70

-10,5





Net income
Million $
Released
Forecast
Spread
-1,70
-4,73
64%
7,70
-2,95
361%
-10,5
-1,56
-572%

88,1

2,38
EPS
 $
Released
Forecast
Spread
-0,04
-0,11
65%
0,16
-0,06
367%
-0,21
-0,05
-335%

1,72

0,04
Announcement Date05/10/201207/31/201211/07/2012

Annual earnings per share is expected at 1.62 USD for 2012 (- 335.1% from 2011). A summary of annual publications and estimates is available below.

Annual results2009201020112012 (e)2013 (e)
Sales
Million $
Released
Forecast
Spread
164
160
2,2%
211
210
0,83%
264
265
-0,10%

393

342
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-49,6
-52,5
5,7%
-45,1
-43,4
-3,9%
-25,2
-21,9
-15%

80,1

13,2
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-53,6
-54,3
1,2%
-51,0
-48,2
-5,8%
-33,2
-30,6
-8,4%

81,4

3,12
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread




-32,9





Net income
Million $
Released
Forecast
Spread
-53,5
-55,7
4,0%
-51,2
-48,1
-6,5%
-32,9
-28,0
-17%

83,7

2,71
EPS
 $
Released
Forecast
Spread
-1,22
-1,27
4,1%
-1,08
-1,04
-4,0%
-0,69
-0,59
-17%

1,62

0,08
Announcement Date02/17/201002/10/201102/23/2012

© 4-traders.com 2013
React to this article
Latest news on AUXILIUM PHARMACEUTICALS,
1d ago AUXILIUM PHARMACEUTICALS : Regulation FD Disclosure, Financial Statements and Ex..
1d ago AUXILIUM PHARMACEUTICALS : Presents STENDRA Data At SMSNA Scientific Meeting
1d ago AUXILIUM PHARMACEUTICALS : Presents XIAFLEX For Peyronie's Disease Data At SMSNA..
2d ago AUXILIUM PHARMACEUTICALS : Other Events (form 8-K)
2d ago AUXILIUM PHARMACEUTICALS : Regulation FD Disclosure, Other Events, Financial Sta..
2d ago AUXILIUM PHARMACEUTICALS : Antares Pharma Appoints James E. Fickenscher, Senior ..
2d ago AUXILIUM PHARMACEUTICALS : Endo Announces Early Termination of HSR Act Waiting P..
2d ago AUXILIUM PHARMACEUTICALS : Endo Announces Early Termination of HSR Act Waiting P..
3d ago AUXILIUM PHARMACEUTICALS : Creation of a Direct Financial Obligation or an Oblig..
11/12 AUXILIUM PHARMACEUTICALS : to Present XIAFLEX and STENDRA Data at SMSNA Scientif..
Advertisement
Chart
Duration : Period :
Auxilium Pharmaceuticals,  Technical Analysis Chart | AUXL | US05334D1072 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF